WILLIAM BOEHRINGER: Open Payments
NPI 1568732121 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 28 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 21 | $177 |
| Amneal Pharmaceuticals LLC | 2 | $53 |
| Merz Pharmaceuticals, LLC | 1 | $32 |
| Eisai Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $15 |
Products named: Apokyn, CREXONT, Xeomin, Leqembi, AUSTEDO XR, REXULTI, NUPLAZID.
Industry payments across NC — which companies pay providers there.
